Document Detail

The Pauson-Khand reaction of medium sized trans-cycloalkenes.
MedLine Citation:
PMID:  23462865     Owner:  NLM     Status:  Publisher    
Medium sized trans-cycloalkenes are unusually reactive in the intermolecular Pauson-Khand reaction (PKR) with regard to typical monocyclic alkenes. This is due to the ring strain imparted by the E stereochemistry. The PKR of these alkenes offers a modular, regioselective and straightforward entry to trans fused [n.3.0] bicyclic scaffolds (n = 6-8).
Agustí Lledó; Aida Fuster; Marc Revés; Xavier Verdaguer; Antoni Riera
Related Documents :
20623095 - Synthesis and antitubercular activity of heteroaromatic isonicotinoyl and 7-chloro-4-qu...
23993605 - Enzymatic oxidation of rutin by horseradish peroxidase: kinetic mechanism and identific...
4009605 - N-phenylpiperazine derivatives with hypocholesterolemic activity.
16793275 - Synthesis of benzenepropanamine analogues as non-detergent spermicides with antitrichom...
15789615 - On the mechanism of biosynthesis of 19-hydroxyprostaglandins of human seminal fluid and...
12720455 - Total synthesis of (+)-asteltoxin.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-3-6
Journal Detail:
Title:  Chemical communications (Cambridge, England)     Volume:  -     ISSN:  1364-548X     ISO Abbreviation:  Chem. Commun. (Camb.)     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-3-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9610838     Medline TA:  Chem Commun (Camb)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Institute for Research in Biomedicine (IRB Barcelona), Baldiri Reixac 10, 08028 Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reversible binding and quantification of heparin and chondroitin sulfate in water using redox-stable...
Next Document:  Radioactive Iodine in the treatment of Medullary Thyroid Carcinoma: a controlled multicenter study.